Security key
M47238122
- Security type / class
- Equity / SHS NEW
- Total 13F shares
- 396,731
- Total 13F value
- $112,946
- Share change
- +224,275
- SEC-reported price per share
- $0.28
- Number of holders
- 11
- Value change
- +$62,648
- Number of buys
- 3
- Number of sells
- 4
Report period
Q2 2024
Institutions
11
Top holders
10
GLMD full security history
Ownership snapshot
Full 13F holder table
Galmed Pharmaceuticals Ltd. SEC filings
Galmed Pharmaceuticals Ltd. company facts
Broader feeds
Ownership snapshot
Top reported holders of GLMD - GALMED PHARMACEUTICALS LTD - SHS NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CVI Holdings, LLC
Disclosed value leader
CVI Holdings, LLC
Comparable rows
0/11
Latest evidence
31 Mar 2024
13F
Highest disclosed value: $24,505
11 rows are not safely comparable across share classes.
Showing 1-6 of 11 holder rows.
Quick read
CVI Holdings, LLC has the largest disclosed position value at $24.5K.
0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens CVI Holdings, LLC's linked filing trail.
Disclosed position value
Top 5
CVI Holdings, LLC
$24.5K
Walleye Capital LLC
$13.8K
TWO SIGMA ADVISERS, LP
$7.7K
TWO SIGMA SECURITIES, LLC
$5.6K
MORGAN STANLEY
$5K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CVI Holdings, LLC |
13F
Company
|
—
denominator unverified
|
$24,505
74,665 shares
|
— | 31 Mar 2024 |
| Walleye Capital LLC |
13F
Company
|
—
denominator unverified
|
$13,788
42,012 shares
|
— | 31 Mar 2024 |
| TWO SIGMA ADVISERS, LP |
13F
Company
|
—
denominator unverified
|
$7,711
22,267 shares
|
— | 31 Mar 2024 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
—
denominator unverified
|
$5,647
16,306 shares
|
— | 31 Mar 2024 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$5,020
14,498 shares
|
— | 31 Mar 2024 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$782
2,260 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
396,731
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
11
Q2 2024 holders
11
Holder diff
0
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|